These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 5774763)

  • 1. Staphylococcus aureus response to lysostaphin in some fermented foods.
    Metcalf RH; Deibel RH
    Appl Microbiol; 1969 Jan; 17(1):63-7. PubMed ID: 5774763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Study of the effectiveness of staphylococcins in biopreservation of Minas fresh (Frescal) cheese with a reduced sodium content.
    Miceli de Farias F; Dos Santos Nascimento J; Cabral da Silva Santos O; de Freire Bastos MDC
    Int J Food Microbiol; 2019 Sep; 304():19-31. PubMed ID: 31151072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lytic action of lysostaphin on susceptible and resistant strains of Staphylococcus aureus.
    Zygmunt WA; Browder HP; Tavormina PA
    Can J Microbiol; 1967 Jul; 13(7):845-53. PubMed ID: 6036889
    [No Abstract]   [Full Text] [Related]  

  • 4. Fate of lysostaphin in milk from individual cows through pasteurization and cheesemaking.
    Van Hekken DL; Wall RJ; Somkuti GA; Powell MA; Tunick MH; Tomasula PM
    J Dairy Sci; 2009 Feb; 92(2):444-57. PubMed ID: 19164654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Studies with lysostaphin. I. Lysostaphin sensitivity of 355 strains of Staph. aureus of human origin].
    Pulverer G
    Z Med Mikrobiol Immunol; 1968; 154(1):40-8. PubMed ID: 5710870
    [No Abstract]   [Full Text] [Related]  

  • 6. Therapeutic applications of lysostaphin against Staphylococcus aureus.
    Jayakumar J; Kumar VA; Biswas L; Biswas R
    J Appl Microbiol; 2021 Sep; 131(3):1072-1082. PubMed ID: 33382154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. epr, which encodes glycylglycine endopeptidase resistance, is homologous to femAB and affects serine content of peptidoglycan cross bridges in Staphylococcus capitis and Staphylococcus aureus.
    Sugai M; Fujiwara T; Ohta K; Komatsuzawa H; Ohara M; Suginaka H
    J Bacteriol; 1997 Jul; 179(13):4311-8. PubMed ID: 9209049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of lysostaphin-producing lactobacilli to control staphylococcal food poisoning in meat products.
    Cavadini C; Hertel C; Hammes WP
    J Food Prot; 1998 Apr; 61(4):419-24. PubMed ID: 9709204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The phage K lytic enzyme LysK and lysostaphin act synergistically to kill MRSA.
    Becker SC; Foster-Frey J; Donovan DM
    FEMS Microbiol Lett; 2008 Oct; 287(2):185-91. PubMed ID: 18721148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of four methods for determining lysostaphin susceptibility of various strains of Staphylococcus aureus.
    Kusuma CM; Kokai-Kun JF
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3256-63. PubMed ID: 16048934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osmotic fragility and viability of lysostaphin-induced staphylococcal spheroplasts.
    Schuhardt VT; Klesius PH
    J Bacteriol; 1968 Sep; 96(3):734-7. PubMed ID: 5732506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lysostaphin treatment of experimental methicillin-resistant Staphylococcus aureus aortic valve endocarditis.
    Climo MW; Patron RL; Goldstein BP; Archer GL
    Antimicrob Agents Chemother; 1998 Jun; 42(6):1355-60. PubMed ID: 9624475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activity of recombinant lysostaphin against Staphylococcus aureus isolates from hospitals in Beijing, China.
    Yang XY; Li CR; Lou RH; Wang YM; Zhang WX; Chen HZ; Huang QS; Han YX; Jiang JD; You XF
    J Med Microbiol; 2007 Jan; 56(Pt 1):71-76. PubMed ID: 17172520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism and suppression of lysostaphin resistance in oxacillin-resistant Staphylococcus aureus.
    Climo MW; Ehlert K; Archer GL
    Antimicrob Agents Chemother; 2001 May; 45(5):1431-7. PubMed ID: 11302806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lysostaphin disrupts Staphylococcus aureus and Staphylococcus epidermidis biofilms on artificial surfaces.
    Wu JA; Kusuma C; Mond JJ; Kokai-Kun JF
    Antimicrob Agents Chemother; 2003 Nov; 47(11):3407-14. PubMed ID: 14576095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lysostaphin: an antistaphylococcal agent.
    Kumar JK
    Appl Microbiol Biotechnol; 2008 Sep; 80(4):555-61. PubMed ID: 18607587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transfection of lysostaphin-treated cells of Staphylococcus aureus.
    Riggs HG; Rosenblum ED
    J Virol; 1969 Jan; 3(1):33-7. PubMed ID: 4239098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bactericidal synergy of lysostaphin in combination with antimicrobial peptides.
    Desbois AP; Coote PJ
    Eur J Clin Microbiol Infect Dis; 2011 Aug; 30(8):1015-21. PubMed ID: 21311938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lysostaphin-induced, osmotically fragile Staphylococcus aureus cells.
    Huber TW; Schuhardt VT
    J Bacteriol; 1970 Jul; 103(1):116-9. PubMed ID: 5423366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro activity of recombinant lysostaphin against Staphylococcus aureus isolates from anterior nares and blood.
    von Eiff C; Kokai-Kun JF; Becker K; Peters G
    Antimicrob Agents Chemother; 2003 Nov; 47(11):3613-5. PubMed ID: 14576128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.